APOB and rheumatoid arthritis: Another similar study suggests that IFX can change the blood lipid level of patients with active RA, TC, TG, HDL-C, LDL-C, and apoB levels increased significantly from baseline, while ATI, LDL-C/HDL-C ratio, and LDL-C/apoB ratio remained unchanged (135).